Intellectual capital and business performance in the pharmaceutical sector of Jordan
Abdel‐Aziz Ahmad Sharabati, Shawqi Naji Jawad, Nick Bontis
Abstract
Abdel‐Aziz Ahmad Sharabati, Shawqi Naji Jawad, Nick Bontis
Abstract
Abstract Purpose – The purpose of this study is to empirically test the relationship between intellectual capital (i.e. human capital, structural capital, relational capital) and business performance within the pharmaceutical sector of Jordan. Design/methodology/approach – A valid research instrument was utilized to conduct a survey of 132 top‐ and middle‐level managers from all 15 members of the Jordanian Association of Pharmaceutical Manufacturers. Findings – A correlation and path analysis were conducted to ascertain the validity of the measures and models. Statistical support was found for the hypothesized relationships. Research limitations/implications – The findings offer valuable insights on the generalizability of intellectual capital in a novel research setting. Practical implications – Intellectual capital measurement is of primary interest for senior executives of pharmaceutical firms in Jordan. Originality/value – The research reported is among only a few to investigate the issue of intellectual capital in Egypt and the first to study pharmaceutical firms.
OpenAlex reports 594 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Purpose – The purpose of this study is to empirically test the relationship between intellectual capital (i.e. human capital, structural capital, relational capital) and business performance within the pharmaceutical sector of Jordan. Design/methodology/approach – A valid research instrument was utilized to conduct a survey of 132 top‐ and middle‐level managers from all 15 members of the Jordanian Association of Pharmaceutical Manufacturers. Findings – A correlation and path analysis were conducted to ascertain the validity of the measures and models. Statistical support was found for the hypothesized relationships. Research limitations/implications – The findings offer valuable insights on the generalizability of intellectual capital in a novel research setting. Practical implications – Intellectual capital measurement is of primary interest for senior executives of pharmaceutical firms in Jordan. Originality/value – The research reported is among only a few to investigate the issue of intellectual capital in Egypt and the first to study pharmaceutical firms.
Key concepts: Intellectual capital, Structural capital, Relational capital, Business, Human capital, Classical economics, Capital (architecture), Financial capital